Literature DB >> 30030746

Clinical features, diagnosis and therapy of pituicytoma: an update.

F J Salge-Arrieta1, R Carrasco-Moro2, V Rodríguez-Berrocal2, H Pian3, J S Martínez-San Millán4, P Iglesias5, L Ley-Urzáiz2.   

Abstract

BACKGROUND: Pituicytomas (PTs) are extremely rare, low-grade glial tumors closely related to the neurohypophyseal axis. Definite conclusions concerning the optimal diagnostic and therapeutic approach to these neoplasms are lacking to date, as most of this information has been presented as case reports.
METHODS: Retrospective review of case reports published in the scientific literature to date, including a new illustrative example treated in our department.
RESULTS: 116 cases were collected. PTs had a higher prevalence in the fifth and sixth decades of life, with a slight male predominance. Main symptoms, which tended to be progressive, included visual field defects and pituitary-hypothalamic dysfunction. Radiologically, PTs were found anywhere along the hypothalamic-pituitary axis mimicking other, more frequent tumors growing in this anatomical region. Surgical treatment included both transcranial or transsphenoidal approaches, and resulted in gross total resection and morbidity rates of 46.8 and 59%, respectively; the latter essentially consisted in anterior and posterior pituitary dysfunction, with limited impact on daily quality of life.
CONCLUSIONS: Due to both low frequency and the absence of pathognomonic clinical and/or radiological features, formulating a suspicion diagnosis of PT represents a considerable challenge even for experienced professionals. The indication for treatment should be made on an individual basis, but it is inescapable in the presence of a visual field defect. The surgical approach has to be tailored according to the topography of the tumor and preoperative symptoms; the greatest challenges in accomplishing a gross total removal are represented by the degree of adherence and vascularization of the PT.

Entities:  

Keywords:  Hypothalamus; Pituicytoma; Pituitary; Transsphenoidal surgery; Tumor

Mesh:

Year:  2018        PMID: 30030746     DOI: 10.1007/s40618-018-0923-z

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  7 in total

1.  Topographical factors guiding the surgical treatment of pituicytomas.

Authors:  Rodrigo Carrasco-Moro; Freddy J Salge-Arrieta; José M Pascual
Journal:  Endocrine       Date:  2019-03-05       Impact factor: 3.633

Review 2.  Primary tumors of the posterior pituitary: A systematic review.

Authors:  Fernando Guerrero-Pérez; Agustina Pia Marengo; Noemi Vidal; Pedro Iglesias; Carles Villabona
Journal:  Rev Endocr Metab Disord       Date:  2019-06       Impact factor: 6.514

3.  Surgical management of pituicytomas: a single-center case series.

Authors:  Amine Trifa; Steven Knafo; Ahmed Maatoug; Matei Militaru; Razvan Copaciu; Nozar Aghakhani; Fabrice Parker
Journal:  Acta Neurol Belg       Date:  2022-03-17       Impact factor: 2.396

4.  Dabrafenib monotherapy for a recurrent BRAFV600E-mutated TTF-1-positive posterior pituitary tumor.

Authors:  Flavie Grenier-Chartrand; Sami Barrit; Marie Lucie Racu; Sylvie Luce; Julien Spitaels; Niloufar Sadeghi-Meibodi; Laetitia Lebrun; Isabelle Salmon; Florence Lefranc; Olivier De Witte
Journal:  Acta Neurochir (Wien)       Date:  2022-01-14       Impact factor: 2.816

5.  Single center study of 53 consecutive patients with pituitary stalk lesions.

Authors:  Mirjana Doknic; Dragana Miljic; Sandra Pekic; Marko Stojanovic; Dragan Savic; Emilija Manojlovic-Gacic; Tatjana Milenkovic; Vera Zdravkovic; Maja Jesic; Dusan Damjanovic; Slobodan Lavrnic; Ivan Soldatovic; Aleksandar Djukic; Milan Petakov
Journal:  Pituitary       Date:  2018-12       Impact factor: 4.107

6.  Pituicytoma Associated with Suspected Cushing's Disease: Two Case Reports and a Literature Review.

Authors:  Tongxin Xiao; Lian Duan; Shi Chen; Lin Lu; Yong Yao; Xinxin Mao; Huijuan Zhu; Hui Pan
Journal:  J Clin Med       Date:  2022-08-17       Impact factor: 4.964

Review 7.  Treatment and prognostic factors of pituicytoma: a single-center experience and comprehensive literature review.

Authors:  Liu-Dong Wei; Chao Li; Da Li; Xing-Ju Liu; Run-Ting Li; Lian-Wang Li; Jun-Mei Wang; Da-Biao Zhou
Journal:  Pituitary       Date:  2021-05-12       Impact factor: 4.107

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.